1h Free Analyst Time
The precision medicine market is forecasted to grow by USD 66.2 billion during 2023-2028, accelerating at a CAGR of 12.34% during the forecast period. The report on the precision medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increasing demand for personalized medicine, and advancements in genomics and proteomics.
The precision medicine market is segmented as below:
By Application
- Oncology
- CNS
- Respiratory
- Immunology
- Others
By Technology
- Bioinformatics
- Gene sequencing
- Drug discovery
- Precision molecular diagnostic
- Big data analytics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the precision medicine market covers the following areas:
- Precision medicine market sizing
- Precision medicine market forecast
- Precision medicine market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the precision medicine market: AbbVie Inc., Amgen Inc., AstraZeneca PLC, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN NV, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine."
According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Biocrates Life Sciences AG
- Bristol Myers Squibb Co.
- Catalent Inc.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- IQVIA Holdings Inc.
- Johnson and Johnson Services Inc.
- Lonza Group Ltd.
- Merck and Co. Inc.
- Novartis AG
- Parexel International Corp.
- Pfizer Inc.
- QIAGEN NV
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Thermo Fisher Scientific Inc.
